Mathias D. Loft
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Marie Krogh's contributions to the study of thyroid physiology and pathophysiology.
Journal: Experimental physiology
Published: January 11, 2025
First-in-Human: Simultaneous Hyperpolarized 1- 13 C-Pyruvate Magnetic Resonance Spectroscopy and 18 F-FDG PET (hyperPET) Imaging of a Patient With Lymphoma.
Journal: Clinical nuclear medicine
Published: November 12, 2024
Routine Use of [64Cu]Cu-DOTATATE PET/CT in a Neuroendocrine Tumor Center: Referral Patterns and Image Results of 2,249 Consecutive Scans.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: April 13, 2024
Editorial for "Quantification of Prostate Cancer Metabolism Using 3D Multiecho bSSFP and Hyperpolarized [1-13 C] Pyruvate: Metabolism Differs Between Tumors of the Same Gleason Grade".
Journal: Journal of magnetic resonance imaging : JMRI
Published: September 29, 2022
An Investigation of Lesion Detection Accuracy for Artificial Intelligence-Based Denoising of Low-Dose 64Cu-DOTATATE PET Imaging in Patients with Neuroendocrine Neoplasms.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: August 24, 2022
Prospective Phase II Trial of [68Ga]Ga-NODAGA-E[c(RGDyK)]2 PET/CT Imaging of Integrin αvβ3 for Prognostication in Patients with Neuroendocrine Neoplasms.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: May 20, 2022
First-in-Humans PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using 18F-labeled Active-Site Inhibited Factor VII (18F-ASIS): Potential as Companion Diagnostic.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: March 04, 2022
A convolutional neural network for total tumor segmentation in [64Cu]Cu-DOTATATE PET/CT of patients with neuroendocrine neoplasms.
Journal: EJNMMI research
Published: February 18, 2022
Activity Dose Reduction in 64Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Impact on Image Quality and Lesion Detection Ability.
Journal: Molecular imaging and biology
Published: October 06, 2021
Prospective Phase II Trial of Prognostication by 68Ga-NOTA-AE105 uPAR PET in Patients with Neuroendocrine Neoplasms: Implications for uPAR-Targeted Therapy.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 14, 2021
[68Ga]Ga-NODAGA-E[(cRGDyK)]2 Angiogenesis PET/MR in a Porcine Model of Chronic Myocardial Infarction.
Journal: Diagnostics (Basel, Switzerland)
Published: July 09, 2021
Initial Experience with 64Cu-DOTATATE Digital PET of Patients with Neuroendocrine Neoplasms: Comparison with Analog PET.
Journal: Diagnostics (Basel, Switzerland)
Published: January 28, 2021
Last Updated: 09/26/2026